Plus Therapeutics Inc (PSTV)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Plus Therapeutics to rebrand as Cerenome and adopt CNSY ticker on August 3 (PSTV)

Company confirms name change and reaffirms 2026 objectives Plus Therapeutics, Inc. (NASDAQ:PSTV), a healthcare company focused on central nervous...

Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding

Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026...

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus...

Plus Therapeutics to Provide Business Update Call on June 30, 2026

HOUSTON, June 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form EFFECT - Notice of Effectiveness

Form 8-K - Current report

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]